S&P 500

5.303,27

0,12%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Sun BioPharma Inc (SNBP)
Sun BioPharma Inc (SNBP) Notícias

SNBP

Sun BioPharma (SNBP)

Sun BioPharma Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SNBP

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
21/06/2023	18:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNBP	Sun BioPharma Inc
04/05/2023	17:18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNBP	Sun BioPharma Inc
28/04/2023	17:28	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SNBP	Sun BioPharma Inc
18/04/2023	17:16	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:SNBP	Sun BioPharma Inc
29/03/2023	17:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNBP	Sun BioPharma Inc
20/03/2023	07:02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SNBP	Sun BioPharma Inc
20/03/2023	07:02	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SNBP	Sun BioPharma Inc
16/03/2023	17:17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SNBP	Sun BioPharma Inc
14/02/2023	16:45	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SNBP	Sun BioPharma Inc
10/02/2023	19:20	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:SNBP	Sun BioPharma Inc
30/01/2023	18:39	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SNBP	Sun BioPharma Inc
26/01/2023	10:07	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	NASDAQ:SNBP	Sun BioPharma Inc
26/01/2023	08:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SNBP	Sun BioPharma Inc
23/01/2023	08:04	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:SNBP	Sun BioPharma Inc
04/11/2022	07:00	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNBP	Sun BioPharma Inc
03/10/2022	18:29	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:SNBP	Sun BioPharma Inc
20/07/2022	07:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SNBP	Sun BioPharma Inc
27/06/2022	09:44	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNBP	Sun BioPharma Inc
23/06/2022	07:01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:SNBP	Sun BioPharma Inc
16/06/2022	09:16	Edgar (US Regulatory)	Notification That a Class of Securities of Successor Issuer Is Demed to Be Registered Pursuant to Section 12(b) (8-k12b)	NASDAQ:SNBP	Sun BioPharma Inc
30/06/2021	07:07	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:SNBP	Sun BioPharma Inc
04/05/2021	17:05	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:SNBP	Sun BioPharma Inc
26/03/2021	09:41	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SNBP	Sun BioPharma Inc
08/12/2020	10:00	GlobeNewswire Inc.	Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Lin...	NASDAQ:SNBP	Sun BioPharma Inc
01/12/2020	13:30	GlobeNewswire Inc.	Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.	NASDAQ:SNBP	Sun BioPharma Inc
12/11/2020	18:10	GlobeNewswire Inc.	Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results	NASDAQ:SNBP	Sun BioPharma Inc
10/11/2020	10:00	GlobeNewswire Inc.	Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select Conference	NASDAQ:SNBP	Sun BioPharma Inc
02/11/2020	10:00	GlobeNewswire Inc.	Sun BioPharma, Inc. Schedules Conference Call on November 12, 2020 to Report 2020 Third Quarter Financial Results	NASDAQ:SNBP	Sun BioPharma Inc
01/09/2020	18:42	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:SNBP	Sun BioPharma Inc
01/09/2020	17:10	GlobeNewswire Inc.	Sun BioPharma, Inc. Closes $10.5 Million Public Offering of Common Stock and Warrants	NASDAQ:SNBP	Sun BioPharma Inc